U.S. Senator Richard Blumenthal Visited NanoViricides Inc. for Update on Coronavirus (COVID-19) Drug Development Efforts
- Written by EQS Asia Business News
DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous 06.04.2020 / 00:24 The issuer is solely responsible for the content of this announcement. SHELTON, CONNECTICUT -- April 6, 2020 -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral drugs based on a novel,... |